HB 3265 Oppose One-Pager – 340B Markups & Transparency Rollbacks
HB 3265 shields hospitals from accountability under the 340B program by eliminating key transparency tools, inflating drug costs for employers, families, and taxpayers. The bill would entrench hospital pricing abuses—where drugs purchased at steep discounts are resold at excessive rates—while removing guardrails that allow plans to detect overcharges or seek cost-saving alternatives. Read our HB 3265 one-pager to learn how the bill undermines fair pricing, raises health costs across the system, and risks eroding the original safety-net purpose of 340B.
